A Narrative Review of the Efficacy of Acupuncture in Chemotherapy-Induced Peripheral Neuropathy in Cancer Patients.

Chemotherapy can damage nerves in the hands and feet, causing pain, numbness, and tingling—a condition called chemotherapy-induced peripheral neuropathy (CIPN). This affects many cancer patients during and after treatment, making daily activities difficult. Researchers reviewed 19 clinical trials involving 1,174 patients to see if acupuncture could help manage these symptoms.

The studies showed that acupuncture significantly reduced neuropathic pain and improved sensory function in patients with CIPN. Acupuncture appeared to work through several mechanisms: it activated the body's natural pain-relieving chemicals (endogenous opioids) and promoted nerve healing through a protein called BDNF that supports neuroplasticity—the brain and nerves' ability to repair and reorganize themselves.

The most effective treatment protocols involved 2-3 acupuncture sessions per week for 4-12 weeks. Practitioners commonly used specific acupuncture points including ST36 (on the lower leg) and LI4 (on the hand). When compared to standard medications like duloxetine, acupuncture showed better safety profiles with fewer side effects and improved patient-reported quality of life outcomes.

What this means for patients: If you're experiencing nerve pain, numbness, or tingling from chemotherapy, acupuncture may offer relief as a complementary treatment alongside your standard cancer care. The evidence suggests it's safe and can improve both pain levels and overall quality of life. The benefits appear to build over several weeks of regular treatment. Always consult with a qualified, licensed acupuncturist experienced in treating cancer patients.

This narrative review analyzed 19 RCTs (n=1174) examining acupuncture's efficacy for chemotherapy-induced peripheral neuropathy (CIPN). Studies demonstrated statistically significant improvements in neuropathic pain reduction and sensory function restoration compared to control groups. Mechanistic evidence indicates acupuncture modulates endogenous opioid pathways for analgesia and upregulates BDNF expression to facilitate neuroplasticity and nerve regeneration.

Optimal treatment protocols identified: 2-3 sessions weekly for 4-12 weeks, with primary point selections including ST36 (Zusanli) and LI4 (Hegu). Comparative effectiveness data showed acupuncture superiority over duloxetine in safety profiles and patient-reported outcomes, with minimal adverse events reported.

Clinical implications: Acupuncture represents an evidence-based adjunctive intervention for CIPN management with multimodal therapeutic mechanisms. Integration into oncology supportive care protocols is warranted, though protocol standardization and additional high-quality RCTs would strengthen clinical guidelines. Consider acupuncture as first-line complementary therapy for patients presenting with CIPN symptoms, particularly those intolerant to or seeking alternatives to pharmacotherapy.